calendar
4,788 catalysts · 4,779 phase readout · 2,339 8k filing · 286 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion
next 91 dayslessmore
MonWedFri
4,788 catalysts · 4,779 phase readout · 2,339 8k filing · 286 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion
Sponsor: Memorial Sloan Kettering Cancer Center. Phase: NA. Conditions: Osteosarcoma
Sponsor: Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba. Phase: PHASE2. Conditions: HIV1 Infection, Multi-treated Patients Who Have Received Multiple Lines of Antiretroviral Treatment, CABOTEGRAVIR, LENACAPAVIR, Stable Oral Antiretroviral Treatment for at Least 6 Months
Sponsor: [Redacted]. Phase: . Conditions:
Sponsor: University Medical Center Groningen. Phase: . Conditions: Huntington Disease
Sponsor: West China Hospital. Phase: . Conditions: HCC - Hepatocellular Carcinoma, Watch & Wait, Surgery
Sponsor: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa. Phase: PHASE1. Conditions: Food Allergy in Children
Sponsor: Catholic University of the Sacred Heart. Phase: . Conditions: Psoriasis
Sponsor: Boehringer Ingelheim. Phase: PHASE3. Conditions: Obesity
Sponsor: Tanta University. Phase: NA. Conditions: Emergence Agitation
Sponsor: South Egypt Cancer Institute. Phase: PHASE2. Conditions: Chemotherapy-induced Peripheral Neuropathy
Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh. Phase: NA. Conditions: Medical Thoracoscopy
Sponsor: Mclean Hospital. Phase: NA. Conditions: Borderline Personality Disorder
Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Colorectal Cancer Prevention
Sponsor: Janssen Research & Development, LLC. Phase: PHASE1. Conditions: Non-Small-Cell Lung Cancer
Sponsor: Persica Pharmaceuticals Ltd. Phase: PHASE1. Conditions: Chronic Low-back Pain
Sponsor: University of Maryland, College Park. Phase: NA. Conditions: Major Adverse Cardiac Event (MACE)
Sponsor: Tianjin Medical University Cancer Institute and Hospital. Phase: PHASE2. Conditions: Small Cell Lung Cancer (SCLC), SCLC, Extensive Stage
Sponsor: Vanda Pharmaceuticals. Phase: PHASE3. Conditions: Moderate-to-severe Chronic Plaque Psoriasis
Sponsor: University of Utah. Phase: NA. Conditions: Cancer, Financial Toxicity
Sponsor: First Affiliated Hospital of Wenzhou Medical University. Phase: PHASE2. Conditions: Idiopathic Pulmonary Fibrosis (IPF)
Sponsor: Ruijin Hospital. Phase: PHASE2. Conditions: Marginal Zone Lymphoma(MZL)
Sponsor: China Medical University Hospital. Phase: NA. Conditions: Adhesive Capsulitis of the Shoulder, Frozen Shoulder
Sponsor: Jessyka Lighthall. Phase: PHASE3. Conditions: Rhinoplasty, Pain Management
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Malignant Pleural Neoplasm
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Post-spinal Hypotension
Sponsor: King Faisal Specialist Hospital & Research Center. Phase: NA. Conditions: Rotator Cuff Tear
Sponsor: Jules Bordet Institute. Phase: . Conditions: Prostate Cancer (Adenocarcinoma)
Sponsor: KU Leuven. Phase: NA. Conditions: Parkinson Disease, Freezing of Gait, Split-belt Treadmill
Sponsor: October University for Modern Sciences and Arts. Phase: NA. Conditions: Soft Tissue Augmentation, Pontic Site Development
Sponsor: Pfizer. Phase: PHASE3. Conditions: Breast Cancer
Sponsor: Rigshospitalet, Denmark. Phase: NA. Conditions: Glucose Metabolism, NAFLD (Nonalcoholic Fatty Liver Disease)
Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Primary IgA Nephropathy
Sponsor: University of California, Los Angeles. Phase: EARLY_PHASE1. Conditions: Anterior Cruciate Ligament Injuries
Sponsor: ANRS, Emerging Infectious Diseases. Phase: . Conditions: Older Adults
Sponsor: University of Zurich. Phase: NA. Conditions: the Immediate and Long-lasting Effects of the X10D Sole on Important Aspects of Walking Function in Healthy Participants, Walking
Sponsor: Shenyang Northern Hospital. Phase: NA. Conditions: Persistent Atrial Fibrillation
Sponsor: The University of Texas at Arlington. Phase: . Conditions: Peripheral Artery Disease (PAD)
Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Multiple Myeloma
Sponsor: Dana-Farber Cancer Institute. Phase: NA. Conditions: Smoking Cessation, Smoking Behaviors, Smoking, Tobacco, Smoking, Cigarette, Smoking (Tobacco) Addiction
Sponsor: Universidade Federal Fluminense. Phase: NA. Conditions: Dental Restoration Failure of Marginal Integrity
Sponsor: Southeast University, China. Phase: NA. Conditions: Aspergillosis Invasive
Sponsor: AstraZeneca. Phase: . Conditions: Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
Sponsor: J.P.S Henriques. Phase: PHASE4. Conditions: Coronary Arterial Disease (CAD), Percutaneous Coronary Intervention (PCI)
Sponsor: Yuzuncu Yil University. Phase: NA. Conditions: TEMPOROMANDIBULAR JOINT DISORDER
Sponsor: University Hospital, Tours. Phase: PHASE2. Conditions: PTSD - Post Traumatic Stress Disorder
Sponsor: Gilead Sciences. Phase: PHASE2. Conditions: HIV-1-infection
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: PHASE1. Conditions: Peritoneal Metastasis, CRC (Colorectal Cancer)
Sponsor: Fatma El Zahraa. Phase: NA. Conditions: Flexible Flatfoot or Pes Planus
Sponsor: Mayo Clinic. Phase: NA. Conditions: Idiopathic Intracranial Hypertension
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia. Phase: . Conditions: AL Amyloidosis, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance